ALgerian Cholecystectomy Outcomes and Determinants Study (AL-CODS)
AL-CODS
Algerian Cholecystectomy Outcomes and Determinants Study
1 other identifier
observational
500
0 countries
N/A
Brief Summary
Cholecystectomy, the surgical removal of the gallbladder, is a common procedure performed to treat benign gallbladder diseases such as cholelithiasis (gallstones), cholecystitis (inflammation of the gallbladder), and biliary dyskinesia. While generally considered safe, this surgery can be associated with significant morbidity and mortality, particularly in certain populations or healthcare settings. Understanding these outcomes and the factors influencing them is crucial for improving patient care and surgical practices. In Algeria, the healthcare landscape presents unique challenges and opportunities for evaluating surgical outcomes. Limited studies have specifically focused on the morbidity and mortality associated with cholecystectomy in this context. This study aims to fill that gap by providing comprehensive data on 30-day postoperative outcomes following cholecystectomy for benign gallbladder diseases in Algeria. Such data is essential for benchmarking current practices, identifying areas for improvement, and ultimately enhancing patient safety and surgical efficacy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2025
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 22, 2024
CompletedFirst Posted
Study publicly available on registry
July 1, 2024
CompletedStudy Start
First participant enrolled
January 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 2, 2025
CompletedJuly 1, 2024
June 1, 2024
6 months
June 22, 2024
June 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Evaluate the 30-day mortality and morbidity
Evaluation of rate of mortality and morbidity at 30 day
occuring in of before 30 day postopérative période.
factors associated with 30-day morbidity and mortality
determinants of the occurence of complications and mortality on or before 30 day in postopérative period
occuring in of before 30 day postopérative période.
Secondary Outcomes (3)
estimate the incidence of incidental gallbladder cancer discovered during cholecystectomy in Algeria.
postoperative periode ( during or after surgical procedure)
estimate the incidence of bile duct injuries following cholecystectomy for benign diseases
occuring in of before 30 day postopérative periode.
assess surgical practices related to cholecystectomy in Algeria.
During surgical procedure ( Cholecystectomy)
Study Arms (1)
Cholecystectomy
patient opérated ( cholecystectomy) and responding to inclusion criteria
Eligibility Criteria
The study population consists of patients aged 18 years and older who undergo cholecystectomy for benign gallbladder diseases in Algeria. This includes patients who have their gallbladders removed due to conditions such as gallstones, cholecystitis, biliary dyskinesia and any other benign pathology
You may qualify if:
- Patients aged 18 years and older.
- Undergoing cholecystectomy.
- Surgery performed in public or private hospitals in Algeria.
- Surgery performed from January 1, 2025, to June 30, 2025.
You may not qualify if:
- Patients younger than 18 years.
- Patients refusing to participate.
- Cholecystectomy performed for Gallbladder cancer.
- Cholecystectomies performed in conjunction with other major surgeries.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Month
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 22, 2024
First Posted
July 1, 2024
Study Start
January 1, 2025
Primary Completion
July 1, 2025
Study Completion
July 2, 2025
Last Updated
July 1, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share
we are not going to share data , but the study will be published in an open acces journal.